These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 31096567)
1. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication. De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts. Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186 [TBL] [Abstract][Full Text] [Related]
3. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers. Lupi LA; Cucielo MS; Silveira HS; Gaiotte LB; Cesário RC; Seiva FRF; de Almeida Chuffa LG Life Sci; 2020 Apr; 247():117435. PubMed ID: 32081661 [TBL] [Abstract][Full Text] [Related]
4. Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro. Fu S; Dong L; Sun W; Xu Y; Gao L; Miao Y Cancer Invest; 2013 Nov; 31(9):616-24. PubMed ID: 24147897 [TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming of the tumour microenvironment. Xing Y; Zhao S; Zhou BP; Mi J FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648 [TBL] [Abstract][Full Text] [Related]
6. Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer. Duechler M; Peczek L; Szubert M; Suzin J Anticancer Res; 2014 Jun; 34(6):2811-9. PubMed ID: 24922644 [TBL] [Abstract][Full Text] [Related]
7. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease. Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599 [TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment: The culprit for ovarian cancer metastasis? Luo Z; Wang Q; Lau WB; Lau B; Xu L; Zhao L; Yang H; Feng M; Xuan Y; Yang Y; Lei L; Wang C; Yi T; Zhao X; Wei Y; Zhou S Cancer Lett; 2016 Jul; 377(2):174-82. PubMed ID: 27131957 [TBL] [Abstract][Full Text] [Related]
9. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications. De Nola R; Loizzi V; Cicinelli E; Cormio G Crit Rev Oncol Hematol; 2021 Jun; 162():103343. PubMed ID: 33930531 [TBL] [Abstract][Full Text] [Related]
10. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma. Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315 [TBL] [Abstract][Full Text] [Related]
11. Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer. Luo X; Xu J; Yu J; Yi P Front Immunol; 2021; 12():692360. PubMed ID: 34248988 [TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer. Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043 [TBL] [Abstract][Full Text] [Related]
13. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer. Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594 [TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Thibault B; Castells M; Delord JP; Couderc B Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056 [TBL] [Abstract][Full Text] [Related]
15. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction. Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998 [TBL] [Abstract][Full Text] [Related]
16. Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth. Bansal R; Tomar T; Ostman A; Poelstra K; Prakash J Mol Cancer Ther; 2012 Nov; 11(11):2419-28. PubMed ID: 22933708 [TBL] [Abstract][Full Text] [Related]
17. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role. Thuwajit C; Ferraresi A; Titone R; Thuwajit P; Isidoro C Med Res Rev; 2018 Jul; 38(4):1235-1254. PubMed ID: 28926101 [TBL] [Abstract][Full Text] [Related]
18. A novel role of metalloproteinase in cancer-mediated immunosuppression. Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168 [TBL] [Abstract][Full Text] [Related]
19. Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo. Fleming JM; Miller TC; Kidacki M; Ginsburg E; Stuelten CH; Stewart DA; Troester MA; Vonderhaar BK Breast Cancer Res; 2012 Jun; 14(3):R97. PubMed ID: 22731827 [TBL] [Abstract][Full Text] [Related]